Once activated, the PI3K/AKT pathway becomes the basis of cancer biology and enhances drug efflux by efficiently expressing ABC transporters and reducing the response of chemotherapeutic drugs, which further caused MDR29,30 (Fig. 2). Here, PIK3CA is linked to cancer.